ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
CytoDyn Inc (QB)

CytoDyn Inc (QB) (CYDY)

0,3156
-0,0004
(-0,13%)
Geschlossen 20 Juli 10:00PM

CytoDyn Inc (QB) (CYDY) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,3156
( -0,13% )
Gebot
0,26
Fragen
0,37
Volumen
959.166
0,3001 Tagesbereich 0,318
0,1031 52-Wochen-Bereich 0,4945
Marktkapitalisierung
Handelsende
0,316
Handelsbeginn
0,3165
Letzte Trade
187
@
0.3156
Letzter Handelszeitpunkt
Finanzvolumen
US$ 296.177
VWAP
0,308786
Durchschnittliches Volumen (3 Mio.)
2.735.385
Ausgegebene Aktien
1.232.433.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-7,92
Gewinn pro Aktie (EPS)
-0,04
Erlöse
-
Nettogewinn
-49,84M

Über CytoDyn Inc (QB)

CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that... CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
CytoDyn Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker CYDY. The last closing price for CytoDyn (QB) was US$0,32. Over the last year, CytoDyn (QB) shares have traded in a share price range of US$ 0,1031 to US$ 0,4945.

CytoDyn (QB) currently has 1.232.433.000 shares in issue. The market capitalisation of CytoDyn (QB) is US$389,45 million. CytoDyn (QB) has a price to earnings ratio (PE ratio) of -7.92.

CYDY Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0004-0.1265822784810.3160.330.2918720460.31204745CS
40.00561.80645161290.310.34990.2515138820.29616041CS
120.084636.62337662340.2310.4470.22787527353850.34383993CS
260.1647109.1451292250.15090.49450.150630527690.28873586CS
520.1746123.8297872340.1410.49450.103127409480.21897455CS
156-0.1244-28.27272727270.441.30.103123025520.268928CS
260-5.4644-94.53979238755.787.70.103127006701.45375278CS

CYDY - Frequently Asked Questions (FAQ)

What is the current CytoDyn (QB) share price?
The current share price of CytoDyn (QB) is US$ 0,3156
How many CytoDyn (QB) shares are in issue?
CytoDyn (QB) has 1.232.433.000 shares in issue
What is the market cap of CytoDyn (QB)?
The market capitalisation of CytoDyn (QB) is USD 389,45M
What is the 1 year trading range for CytoDyn (QB) share price?
CytoDyn (QB) has traded in the range of US$ 0,1031 to US$ 0,4945 during the past year
What is the PE ratio of CytoDyn (QB)?
The price to earnings ratio of CytoDyn (QB) is -7,92
What is the reporting currency for CytoDyn (QB)?
CytoDyn (QB) reports financial results in USD
What is the latest annual profit for CytoDyn (QB)?
The latest annual profit of CytoDyn (QB) is USD -49,84M
What is the registered address of CytoDyn (QB)?
The registered address for CytoDyn (QB) is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the CytoDyn (QB) website address?
The website address for CytoDyn (QB) is www.cytodyn.com
Which industry sector does CytoDyn (QB) operate in?
CytoDyn (QB) operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BMMJBody and Mind Inc (CE)
US$ 0,006
(599.900,00%)
8,2k
GSIHGeneral Steel Holdings Inc (CE)
US$ 0,0501
(24.950,00%)
600
ARVLFArrival (CE)
US$ 0,0002
(19.900,00%)
7,81k
PIKMKidpik Corporation (CE)
US$ 0,0111
(11.000,00%)
5,42k
GXXMGex Management Inc (PK)
US$ 0,0001
(9.900,00%)
1,41M
HSTCHST Global Inc (PK)
US$ 0,0001
(-99,98%)
666
WGMCFWinston Gold Corp (CE)
US$ 0,000001
(-99,90%)
7,9k
ELYSElys BMG Group Inc (CE)
US$ 0,000001
(-99,75%)
5,44k
BLSPBlue Sphere Corporation (CE)
US$ 0,000001
(-99,50%)
161,89k
GMZPGemz Corporation (PK)
US$ 0,000001
(-99,50%)
6,12M
SMCESMC Entertainment Inc (PK)
US$ 0,0006
(0,00%)
264,01M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,0011
(0,00%)
181,4M
GTCHGBT Technologies Inc (PK)
US$ 0,0001
(0,00%)
175,39M
BFCHBitFrontier Capital Holdings Inc (PK)
US$ 0,0002
(-33,33%)
133,06M
ILSTInternational Star Inc (PK)
US$ 0,0004
(0,00%)
114,72M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock